Financhill
Sell
28

XFOR Quote, Financials, Valuation and Earnings

Last price:
$0.23
Seasonality move :
14.76%
Day range:
$0.23 - $0.25
52-week range:
$0.23 - $1.60
Dividend yield:
0%
P/E ratio:
7.78x
P/S ratio:
--
P/B ratio:
1.85x
Volume:
2.1M
Avg. volume:
1.6M
1-year change:
-82.99%
Market cap:
$41.1M
Revenue:
$2.6M
EPS (TTM):
-$0.19
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $3M -- -- -- $2.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- $797K
Gross Profit -- -- -- -- $1.8M
Gross Profit Margin -- -- -- -- 68.83%
 
R&D Expenses $41.9M $50.6M $61.1M $72M $81.6M
Selling, General & Admin $20.9M $24.7M $27M $35.5M $61.5M
Other Inc / (Exp) $306K -$9.7M -$2M $7.6M $107.3M
Operating Expenses $62.9M $75.3M $88.1M $107.5M $143.2M
Operating Income -$59.9M -$75.3M -$88.1M -$107.5M -$141.4M
 
Net Interest Expenses $2.4M $3.6M $3.8M $1.2M $3M
EBT. Incl. Unusual Items -$62M -$88.7M -$93.8M -$101.1M -$37.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $148K $17K $28K $78K $310K
Net Income to Company -$62.1M -$88.7M -$93.9M -$101.2M -$37.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$62.1M -$88.7M -$93.9M -$101.2M -$37.5M
 
Basic EPS (Cont. Ops) -$3.09 -$3.99 -$1.52 -$0.57 -$0.19
Diluted EPS (Cont. Ops) -$3.09 -$3.99 -$1.52 -$0.57 -$0.19
Weighted Average Basic Share $20.1M $25.7M $63.5M $177.8M $201.1M
Weighted Average Diluted Share $20.1M $25.7M $63.5M $177.8M $201.1M
 
EBITDA -$58.9M -$84.5M -$89.3M -$94.9M -$27.6M
EBIT -$59.3M -$85M -$89.8M -$95.3M -$28.4M
 
Revenue (Reported) $3M -- -- -- $2.6M
Operating Income (Reported) -$59.9M -$75.3M -$88.1M -$107.5M -$141.4M
Operating Income (Adjusted) -$59.3M -$85M -$89.8M -$95.3M -$28.4M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- -- -- -- $1.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- $302K
Gross Profit -- -- -- -- $1.1M
Gross Profit Margin -- -- -- -- 78.94%
 
R&D Expenses $12.3M $12.2M $19M $15.3M $21.7M
Selling, General & Admin $5.4M $7.1M $6.6M $9.9M $15.1M
Other Inc / (Exp) -$26K -$10M -$2.6M $6.5M -$2.8M
Operating Expenses $17.7M $19.3M $25.6M $25.2M $36.8M
Operating Income -$17.7M -$19.3M -$25.6M -$25.2M -$35.7M
 
Net Interest Expenses $719K $922K $946K $441K $1M
EBT. Incl. Unusual Items -$18.4M -$30.2M -$29.1M -$19.1M -$39.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $3K $14K $33K $258K
Net Income to Company -$18.4M -$30.2M -$29.1M -$19.1M -$39.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$18.4M -$30.2M -$29.1M -$19.1M -$39.8M
 
Basic EPS (Cont. Ops) -$0.91 -$1.24 -$0.29 -$0.09 -$0.20
Diluted EPS (Cont. Ops) -$0.91 -$1.24 -$0.29 -$0.09 -$0.20
Weighted Average Basic Share $20.2M $29M $121.7M $199M $202.9M
Weighted Average Diluted Share $20.2M $29M $121.7M $199M $202.9M
 
EBITDA -$17.6M -$29.1M -$27.8M -$17.1M -$37M
EBIT -$17.7M -$29.3M -$27.9M -$17.2M -$37.3M
 
Revenue (Reported) -- -- -- -- $1.4M
Operating Income (Reported) -$17.7M -$19.3M -$25.6M -$25.2M -$35.7M
Operating Income (Adjusted) -$17.7M -$29.3M -$27.9M -$17.2M -$37.3M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $41.9M $50.6M $61.1M $72M $81.6M
Selling, General & Admin $20.9M $24.7M $27M $35.5M $61.5M
Other Inc / (Exp) $275K -$9.7M -$2M $7.6M $107.3M
Operating Expenses $62.9M $75.3M $88.1M $107.5M $143.2M
Operating Income -$59.9M -$75.3M -$88.1M -$107.5M -$141.4M
 
Net Interest Expenses $2.4M $3.6M $3.8M $1.2M $3M
EBT. Incl. Unusual Items -$62M -$88.7M -$93.8M -$101.1M -$37.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $148K $17K $28K $78K $310K
Net Income to Company -$62.1M -$88.7M -$93.9M -$101.2M -$37.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$62.1M -$88.7M -$93.9M -$101.2M -$37.5M
 
Basic EPS (Cont. Ops) -$3.10 -$4.04 -$1.87 -$0.59 -$0.19
Diluted EPS (Cont. Ops) -$3.10 -$4.04 -$1.87 -$0.59 -$0.19
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$58.9M -$84.5M -$89.3M -$94.9M -$27.6M
EBIT -$59.3M -$85M -$89.8M -$95.3M -$28.4M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$59.9M -$75.3M -$88.1M -$107.5M -$141.4M
Operating Income (Adjusted) -$59.3M -$85M -$89.8M -$95.3M -$28.4M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue -- -- -- $2.6M --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $797K --
Gross Profit -- -- -- $1.8M --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $50.6M $61.1M $72M $81.6M --
Selling, General & Admin $24.7M $27M $35.5M $61.5M --
Other Inc / (Exp) -$9.7M -$2M $7.6M $107.3M --
Operating Expenses $75.3M $88.1M $107.5M $143.2M --
Operating Income -$75.3M -$88.1M -$107.5M -$141.4M --
 
Net Interest Expenses $3.6M $3.8M $1.2M $3M --
EBT. Incl. Unusual Items -$88.7M -$93.8M -$101.1M -$37.1M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $17K $28K $78K $310K --
Net Income to Company -$88.7M -$93.9M -$101.2M -$37.5M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$88.7M -$93.9M -$101.2M -$37.5M --
 
Basic EPS (Cont. Ops) -$4.04 -$1.87 -$0.59 -$0.19 --
Diluted EPS (Cont. Ops) -$4.04 -$1.87 -$0.59 -$0.19 --
Weighted Average Basic Share $102.9M $274.1M $710.7M $804.2M --
Weighted Average Diluted Share $102.9M $274.1M $710.7M $804.6M --
 
EBITDA -$84.5M -$89.3M -$94.9M -$27.6M --
EBIT -$85M -$89.8M -$95.3M -$28.4M --
 
Revenue (Reported) -- -- -- $2.6M --
Operating Income (Reported) -$75.3M -$88.1M -$107.5M -$141.4M --
Operating Income (Adjusted) -$85M -$89.8M -$95.3M -$28.4M --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $78.7M $81.8M $121.7M $99.2M $55.7M
Short Term Investments -- -- -- $15M $46.4M
Accounts Receivable, Net -- -- -- -- $1.1M
Inventory -- -- -- -- $2.8M
Prepaid Expenses -- -- -- -- --
Other Current Assets $3.7M $5.3M $5.8M $7.3M $5.6M
Total Current Assets $83.3M $87.9M $128.7M $122.1M $112.2M
 
Property Plant And Equipment $9.2M $10.2M $8.3M $6.4M $4.8M
Long-Term Investments -- -- -- -- --
Goodwill $27.1M $17.4M $17.4M $17.4M $17.4M
Other Intangibles -- -- -- -- $10M
Other Long-Term Assets $3.3M $1.7M $1.2M $1.4M $2.1M
Total Assets $122.9M $117.2M $155.6M $147.3M $146.4M
 
Accounts Payable $3.1M $4.3M $7.8M $8.9M $8.6M
Accrued Expenses $4.3M $2.5M $5.4M $4.6M $10M
Current Portion Of Long-Term Debt -- $795K $1.3M -- --
Current Portion Of Capital Lease Obligations $786K $1.1M $1.2M $1.1M $1.3M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $11.9M $14M $22.3M $22.9M $32.9M
 
Long-Term Debt $33.2M $33.1M $32.3M $54.6M $75.4M
Capital Leases -- -- -- -- --
Total Liabilities $50.1M $52.8M $81.5M $96.2M $124.3M
 
Common Stock $16K $28K $122K $167K $171K
Other Common Equity Adj -$119K -$119K -$119K -$119K -$122K
Common Equity $72.8M $64.4M $74.1M $51.1M $22.1M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $72.8M $64.4M $74.1M $51.1M $22.1M
 
Total Liabilities and Equity $122.9M $117.2M $155.6M $147.3M $146.4M
Cash and Short Terms $78.7M $81.8M $121.7M $114.2M $102.1M
Total Debt $33.2M $33.9M $33.6M $54.6M $75.4M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $78.7M $81.8M $121.7M $99.2M $55.7M
Short Term Investments -- -- -- $15M $46.4M
Accounts Receivable, Net -- -- -- -- $1.1M
Inventory -- -- -- -- $2.8M
Prepaid Expenses -- -- -- -- --
Other Current Assets $3.7M $5.3M $5.8M $7.3M $5.6M
Total Current Assets $83.3M $87.9M $128.7M $122.1M $112.2M
 
Property Plant And Equipment $9.2M $10.2M $8.3M $6.4M $4.8M
Long-Term Investments -- -- -- -- --
Goodwill $27.1M $17.4M $17.4M $17.4M $17.4M
Other Intangibles -- -- -- -- $10M
Other Long-Term Assets $3.3M $1.7M $1.2M $1.4M $2.1M
Total Assets $122.9M $117.2M $155.6M $147.3M $146.4M
 
Accounts Payable $3.1M $4.3M $7.8M $8.9M $8.6M
Accrued Expenses $4.3M $2.5M $5.4M $4.6M $10M
Current Portion Of Long-Term Debt -- $795K $1.3M -- --
Current Portion Of Capital Lease Obligations $786K $1.1M $1.2M $1.1M $1.3M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $11.9M $14M $22.3M $22.9M $32.9M
 
Long-Term Debt $33.2M $33.1M $32.3M $54.6M $75.4M
Capital Leases -- -- -- -- --
Total Liabilities $50.1M $52.8M $81.5M $96.2M $124.3M
 
Common Stock $16K $28K $122K $167K $171K
Other Common Equity Adj -$119K -$119K -$119K -$119K -$122K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $72.8M $64.4M $74.1M $51.1M $22.1M
 
Total Liabilities and Equity $122.9M $117.2M $155.6M $147.3M $146.4M
Cash and Short Terms $78.7M $81.8M $121.7M $114.2M $102.1M
Total Debt $33.2M $33.9M $33.6M $54.6M $75.4M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$62.1M -$88.7M -$93.9M -$101.2M -$37.5M
Depreciation & Amoritzation $351K $499K $513K $419K $796K
Stock-Based Compensation $5.4M $6.2M $5.2M $8.7M $8.2M
Change in Accounts Receivable -- -- -- -- -$1.1M
Change in Inventories -- -- -- -- -$2.8M
Cash From Operations -$58.8M -$70.9M -$77.1M -$96.5M -$130.9M
 
Capital Expenditures $1.4M $615K $103K $60K $7.3M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.4M -$615K -$103K -$14.9M $67M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $12.4M -- -- $22.5M $20M
Long-Term Debt Repaid -- -- -$795K -$2.1M --
Repurchase of Common Stock -$277K -$2M -- -- --
Other Financing Activities -$278K -- -$4.8M -$631K --
Cash From Financing $12.4M $74.2M $117.2M $88.5M $20.3M
 
Beginning Cash (CF) $128.1M $80.7M $83.1M $123M $100.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$47.8M $2.7M $40M -$22.9M -$43.6M
Ending Cash (CF) $80.7M $83.1M $123M $100.2M $56.5M
 
Levered Free Cash Flow -$60.2M -$71.5M -$77.2M -$96.6M -$138.2M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$18.4M -$30.2M -$29.1M -$19.1M -$39.8M
Depreciation & Amoritzation $103K $132K $124K $62K $273K
Stock-Based Compensation $1.4M $1.6M $1.1M $2.5M $2.2M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- -$372K
Cash From Operations -$17.5M -$19.1M -$19.1M -$27.7M -$33M
 
Capital Expenditures $302K $13K $34K $35K $41K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$302K -$13K -$34K -$4.8M -$8.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $7.5M -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock $36K -- -- -- --
Other Financing Activities -- -- -$4.8M -- --
Cash From Financing $7.6M $24.6M $60.6M $97K $135K
 
Beginning Cash (CF) $90.7M $77.7M $81.1M $132.6M $98.2M
Foreign Exchange Rate Adjustment $162K -$116K $363K $127K -$244K
Additions / Reductions -$10.2M $5.5M $41.5M -$32.5M -$41.5M
Ending Cash (CF) $80.7M $83.1M $123M $100.2M $56.5M
 
Levered Free Cash Flow -$17.8M -$19.1M -$19.1M -$27.8M -$33M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$62.1M -$88.7M -$93.9M -$101.2M -$37.5M
Depreciation & Amoritzation $351K $499K $513K $419K $796K
Stock-Based Compensation $5.4M $6.2M $5.2M $8.7M $8.2M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$58.8M -$70.9M -$77.1M -$96.5M -$130.9M
 
Capital Expenditures $1.4M $615K $103K $60K $7.3M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.4M -$615K -$103K -$14.9M $67M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $12.4M -- -- -- --
Long-Term Debt Repaid -- -- -$795K -$2.1M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$4.8M -- --
Cash From Financing $12.4M $74.2M $117.2M $88.5M $20.3M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$47.8M $2.7M $40M -$22.9M -$43.6M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$60.2M -$71.5M -$77.2M -$96.6M -$138.2M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders -$88.7M -$93.9M -$101.2M -$37.5M --
Depreciation & Amoritzation $499K $513K $419K $796K --
Stock-Based Compensation $6.2M $5.2M $8.7M $8.2M --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -$2.8M --
Cash From Operations -$70.9M -$77.1M -$96.5M -$130.9M --
 
Capital Expenditures $615K $103K $60K $7.3M --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$615K -$103K -$14.9M $67M --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $22.5M $20M --
Long-Term Debt Repaid -- -$795K -$2.1M -- --
Repurchase of Common Stock -$2M -- -- -- --
Other Financing Activities -- -$4.8M -$631K -- --
Cash From Financing $74.2M $117.2M $88.5M $20.3M --
 
Beginning Cash (CF) $371.6M $280.7M $487.5M $407.7M --
Foreign Exchange Rate Adjustment -$319K -$105K $99K -$156K --
Additions / Reductions $2.7M $40M -$22.9M -$43.6M --
Ending Cash (CF) $374M $320.6M $464.7M $363.9M --
 
Levered Free Cash Flow -$71.5M -$77.2M -$96.6M -$138.2M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

3 Smartest Dividend Stocks to Buy Now
3 Smartest Dividend Stocks to Buy Now

When the market entered a correction in February and March,…

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Buy
80
CORT alert for Apr 1

Corcept Therapeutics [CORT] is down 15.25% over the past day.

Sell
16
PCVX alert for Apr 1

Vaxcyte [PCVX] is down 2.01% over the past day.

Sell
47
RGC alert for Apr 1

Regencell Bioscience Holdings [RGC] is down 3.23% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock